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Ultraviolet (UV) irradiation is an established treatment for inﬂammatory skin diseases, although the precise mode of
action is still unclear. Activating and suppressive effects on mast cell (MC) mediator release have been described.
The aim of this study was to investigate systematically the effects of UVB, UVA-1, and psoralen plus UVA-1 at
therapeutic doses on skin-derived human MC. Baseline and stimulated release of histamine, tryptase, and of
interleukin (IL)-6, IL-8 and tumor necrosis factor-alpha (TNF-a) were examined. In resting MC, UV light induced a
slight, yet significant histamine release corresponding to enhanced surface levels of lysosome-associated mem-
brane proteins (LAMP). In contrast, UV pre-treatment caused a marked suppression of the anti-IgE-induced his-
tamine release, accompanied by a diminished, anti-IgE-mediated increase in LAMP expression. The secretion of
IL-6, IL-8, and TNF-a was inhibited in resting and activated MC, suggesting a different mode of action. Regarding
the importance of MC in a variety of allergic and inﬂammatory processes, our data show a high susceptibility of this
cell type towards UV light, which seems to partially depend on the state of cellular activation. Immunosuppressive
effects predominate in activated MC, thus corresponding with the beneﬁcial effects in inﬂammatory diseases,
whereas in resting MC, both stimulatory and inhibitory effects are observed.
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Ultraviolet (UV) light is known to cause proinflammatory ef-
fects, as is well illustrated by overdosing in the context of
sunburn. Its anti-inflammatory and immunomodulatory
functions, however, have also been recognized since many
decades. Selected wavelengths and controlled dosage of
UV irradiation are applied widely in the treatment of diverse
skin diseases such as psoriasis and atopic dermatitis. The
possible mechanisms associated with the beneficial effects
of this therapy have been extensively studied in keratin-
ocytes, lymphocytes, Langerhans cells, and infiltrating le-
ukocytes (reviewed in Krutmann and Morita, 1999). Little is
known, however, about UV-induced changes in skin mast
cells (MC), even though UV treatment is well appreciated
as beneficial in pruritic diseases and in cutaneous mast-
ocytosis (reviewed in Hartmann et al, 2001).
A limited number of studies have been published on the
in vitro effect of UV light on rodent MC, which differ sub-
stantially from their human counterparts, such that results
can be hardly transferred to the human system (Metcalfe
et al, 1997). Although the reported data are not always in
accord (Fjellner and Hagermark, 1982; Danno et al, 1988;
Glover et al, 1989; Yen et al, 1990; Amano et al, 1998; Mio
et al, 1999; Graevskaya et al, 2000), they clearly revealed
that MC histamine release is subject to modulation by UV
light. In fact, MC-derived histamine has been suspected to
play a dominant role in UV-induced immunosuppression
(Hart et al, 2001). Furthermore, there are clinical observa-
tions to support a significant role for human MC in the
beneficial effects imparted by UV light in the therapy of skin
diseases (Kolde et al, 1984; Yen et al, 1991). Moreover, we
recently showed that human skin MC are resistant to UV-
induced apoptosis, whereas immature leukemic MC are
highly susceptible to UV-triggered cell death (Guhl et al,
2003). Other clinical findings that support the concept of
human MC as targets of UV light include the lower density
of MC granules after psoralen plus ultraviolet light A (PUVA)
treatment in mastocytosis patients, the markedly reduced
tissue levels of histamine, and a diminished ability of the
skin to generate leukotrienes (Kolde et al, 1984; Czarnetzki
et al, 1985). Mueller and Meffert (1994) reported on in-
creased histamine serum levels after UVA-1, but not after
UVB treatment, whereas in contrast, UVB irradiation was
found to be an effective histamine liberator by Walsh
(Walsh, 1995). In summary, these data imply that UV light
may affect human MC directly by altering the cell’s potential
of mediator release. Obviously, however, the precise out-
come seems to differ, depending on the specific conditions
such as irradiation wavelengths and the presence of stim-
ulating agents in the cell’s environment.
To address this issue in a systematic manner, we inves-
tigated MC purified from human skin and compared the
Abbreviations: IL, interleukin; LAMP, lysosome-associated mem-
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effects of different irradiation protocols on spontaneous and
induced release of typical MC mediators.
Results
Effects of UV light on stimulated mediator release First,
we tested the effects of UV irradiation on the release of
histamine induced by cross-linking of high-affinity IgE re-
ceptor (FceRI). Skin MC were exposed to various doses of
UVB (0,5, 25, 50, 75, 100 mJ per cm2), UVA-1 (0, 5, 10, 15,
20, 25 J per cm2), or PUVA-1 (0, 1, 2, 3, 4, 5 J per cm2) and
then left in culture for 24 h prior to anti-IgE challenge. All
types of UV treatment led to striking inhibition of stimulated
histamine liberation in a clearly dose-dependent manner
(Fig 1, black bars) Interestingly, UVA-1 turned out most po-
tent with over 90% inhibition at 25 J per cm2, whereas
maximum suppression of UVB and PUVA-1 treatment
was in the range of 60%–70%. In all settings, the suppres-
sion of histamine release induced by calcium ionophore
A23187 (Fig 1, hatched bars) closely approximated that of
anti-IgE (Fig 1, black bars), indicating a largely receptor-in-
dependent effect.
UV light triggers histamine release from resting MC To
address the issue of whether MC would release higher lev-
els of histamine following irradiation, cells were treated with
UV light as above, left in culture for 24 h, and then subjected
to histamine release assays for 30 min in the absence of
additional stimuli. In stark contrast to the reduction of stim-
ulated histamine release, all types of UV light caused a
concentration-dependent release of histamine from non-
stimulated MC (data shown in Fig S7 of full-text version;
Fig S8). The next issue was to determine histamine levels
that had accumulated in the cell culture supernatant 24 h
post-irradiation. Indeed increased extracellular histamine
levels were detectable in all UV settings compared with
control (Fig 2). In summary, it thus appears likely that his-
tamine secretion from irradiated MC constantly supplies low
to intermediate levels of histamine to surrounding cells and
that this process still takes place long after irradiation has
ceased.
UV light inhibits baseline and stimulated cytokine se-
cretion from MC Both spontaneous and anti-IgE-triggered
levels of interleukin (IL)-6 and IL-8 were substantially sup-
pressed by the three types of UV treatment, with UVA-1
being most potent (see Fig S11 full-text version online). As
observed by us before, IL-8 release is only slightly enhanced
by FceRI cross-linking, whereas IL-6 is apparently not af-
fected at all or even slightly downregulated (Babina et al,
2004). Anti-IgE, however, displays a very clear inducing
Figure 1
Ultraviolet (UV) treatment inhibits stimulated histamine release
from skin mast cells (MC). Skin MC were irradiated with UV light at the
doses indicated, kept in medium for 24 h, and then stimulated by either
anti-IgE (black bars) or the calcium ionophore A 23187 (hatched bars).
Results (net histamine release¼ (stimulated histamine releasespon-
taneous histamine release)/total cellular histamine) are expressed
in relation to the value obtained for non-irradiated control cells (sham
or 8 methoxypsoralen were set at 100%) and are the mean  SEM of
7–10 independent tests. po0.05; po0.01; compared with non-
irradiated control cells.
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effect on tumor necrosis factor-alpha (TNF-a) secretion.
This up-modulating activity of anti-IgE on TNF-a was com-
pletely abrogated by UV irradiation, whereas the very low
baseline level remained unaffected. In contrast to what was
observed for the preformed mediator histamine, the release
of these mainly de novo synthesized MC mediators were in-
hibited irrespective of whether cells were stimulated or not.
Discussion
UV light can mediate either pro- or anti-inflammatory effects
on the skin through its action on different cells including
keratinocytes, melanocytes, fibroblasts as well as infiltrating
leukocytes. Our work provides evidence that human MC
need to be viewed as additional major targets in the skin
that are involved in immunomodulation by UV light, as has
been suspected previously (Hart et al, 2001, 2002). Inter-
estingly, UV light displayed a dual effect on MC by triggering
slight but significant histamine release from resting MC, but
suppressing this same release up to 90% when cells were
appropriately stimulated. The inhibition of histamine release
was accompanied by reduced secretion of tryptase (data
shown in full-text version), suggesting that UV light had a
negative impact on the discharge of MC granules into the
outer cell environment.
MC are well known to produce several cytokines in ad-
dition to the preformed histamine (Artuc et al, 1999; Bradd-
ing and Holgate, 1999). One significant finding of this study
was therefore the inhibition of proinflammatory cytokines in
human skin MC detected after all types of UV irradiation and
irrespective of the activation state of the cell. Together with
the data on preformed mediators, UV light obviously turns
skin MC insensitive or even inert towards different types of
stimulation, which is illustrated by the counteracting effect
of UV light on the production of TNF-a where UV light fully
impedes the stimulatory capacity of anti-IgE.
From a more physiological or clinical viewpoint, our data
demonstrate that the bivalent effects of UV light on the skin
are impressively reflected at the level of the skin MC, there-
by possibly explaining some clinical observations. The low,
but long-lasting histamine release from resting MC may
contribute to UV-induced erythema, either directly (Clydes-
dale et al, 2001) or through coupled prostaglandin synthe-
sis, a key feature of sunburn-associated inflammation
(Pentland et al, 1990). Our findings are largely in line with
data showing UV-mediated reduction of skin histamine lev-
els in cutaneous mastocytosis (Kolde et al, 1984; Czarnetzki
et al, 1985), a condition in which MC appear to be slightly
but constantly activated (Escribano et al, 2002). But the fact
that inhibitory effects are not limited to histamine provides a
plausible explanation for the advantageous anti-inflamma-
tory actions of UV treatment in a number of other derma-
tological diseases that are not or not primarily histamine
dependent, such as atopic dermatitis and psoriasis. Taken
together, the present findings identify human skin MC as
important targets of UV-induced immunomodulation. They
help explain both the adverse effects of UV light, with sun-
burn reactions being the most prominent example, and the
beneficial anti-inflammatory effects during therapy.
This study has been supported by a grant from BMBF (01GC9702/0-7).
Parts of these data have been presented as a poster at the CIA Meet-
ing 2002.
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Figure S1
Spectral irradiance as a function of wavelength. Spectral irradiance
as a function of wavelength for the UVB device, UV 800 equipped with
TL-12 tubes (1) and the UVA-1 ﬂuorescence tube TL-10 (2) determined
at the distance of use (50 cm, 5 cm) without solution (a) and after
transmission of the solution (b).
Figure S2
UV-treatment inhibits stimulated histamine release from skin mast
cells. Skin mast cells were irradiated with UV-light at the doses
indicated, kept in medium for 24 h and then stimulated by either anti-IgE
(black bars) or the calcium ionophore A 23187 (hatched bars).
Histamine levels in the supernatants and lysates were assessed as
described under Materials and Methods. Results [net histamine
release¼ (stimulated histamine release – spontaneous histamine
release)/total cellular histamine] are expressed in relation to the value
obtained for non irradiated control cells (sham or 8-MOP were set at
100%) and are the mean  SEM of 7–10 independent tests. po0.05;
po0.01; compared to non irradiated control cells.
Figure S3
UV-treatment inhibits anti IgE stimulated tryptase release from skin
mast cells. Cells were treated with 75 mJ per cm2 UVB, 15 J per cm2
UVA-1 and 5 J per cm2 PUVA-1 and levels of released tryptase
assessed in relation to a standard curve using the recombinant enzyme
by proteolytic cleavage of a speciﬁc substrate. Results are expressed in
percent of total tryptase content and are the mean  SEM of 7–9
independent tests. po0.05. compared to sham-treated cells and 8-
MOP included as a control for PUVA-1 (which were set at 100%).
Figure S4
Time-dependent inhibition by UV-light of stimulated histamine
release from skin mast cells. Cells were irradiated with doses of 75 mJ
per cm2 (UVB), 15 J per cm2 (UVA-1), or 5 J per cm2 (PUVA-1) and then
Figure 2
Effects of ultraviolet (UV) light on accumulated histamine levels.
Cells were irradiated with 75 mJ per cm2 (UVB), 15 J per cm2 (UVA-1),
and 5 J per cm2 (PUVA-1), and left in culture for 24 h. Sham- and MOP-
treated cells represent non-irradiated controls. Accumulated histamine
content in supernatants was assessed by the enzyme immuno assay
(EIA) technique. Results are the mean  SEM of nine independent
assays. po0.05, compared with sham- and 8-methoxypsoralen-treat-
ed cells, respectively.
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left in standard medium for the times indicated on the abscissa prior to
challenge with anti-IgE (black bars) or the calcium ionophore A 23187
(hatched bars). Results are the mean  SEM of 6 independent tests.
po0.05. compared to non irradiated control cells.
Figure S5
UV-light does not affect mast cell survival. Skin mast cells were
irradiated with 75 mJ per cm2 (UVB), 15 J per cm2 (UVA-1) and 5 J per
cm2 (PUVA-1) and kept in culture for the times indicated in the ﬁgure.
Cell numbers were assessed by automatic casy cell counter. The bars
show the mean of the cell number of 6 independent experiments þ /
SEM. No differences were found between irradiated MC and the two
non irradiated control groups (sham and 8-MOP).
Figure S6
UV-light reduces total histamine content of skin mast cells in a
time-dependent manner. Cells were irradiated with the UV-doses
stated in the ﬁgure and then left in standard medium for the times
indicated on the abscissa. Total histamine content was assessed in cell
lysates relative to a standard curve. 8-MOP and sham treated cells
served as negative controls Data are the mean  SEM of 6 independent
tests.
Figure S7
UV-light provokes spontaneous histamine release from skin mast
cells. Cells were irradiated with various doses of UV-light. After 24 h in
standard medium, spontaneous histamine release was assessed. Data
show the mean  SEM of 7–10 independent tests. po0,05.
Figure S8
Effects of UV-light on spontaneous histamine release over the
time. Cells were irradiated with the indicated doses of UV-light, and kept
in culture medium for different times as shown on the abscissa,
afterwards spontaneous histamine release was assessed. Data are the
mean  SEM of 6 independent assays.
Figure S9
Effects of UV-light on accumulated histamine levels. Cells were
irradiated with 75 mJ per cm2 (UVB), 15 J per cm2 (UVA-1) and 5 J per
cm2 (PUVA-1), and left in culture for 24 h. Sham- and MOP-treated cells
represent non irradiated controls. Accumulated histamine content in
supernatants was assessed by EIA technique. Results are the
mean  SEM of 9 independent assays. po0.05, compared to sham-
and 8-MOP-treated cells, respectively.
Figure S10
UV-light affects spontaneous and induced surface expression of
CD107a. Cells were irradiated with 75 mJ per cm2 (UVB), 15 J per cm2
(UVA-1) and 5 J per cm2 (PUVA-1), and then kept in culture for 24 h.
Cell surface expression of CD107a was assessed by ﬂow-cytometry
with (black lines) or without (grey lines) stimulation by anti-IgE for 30
min. Representative histograms of 5 independent assays are shown.
Figure S11
UV-light inhibits the release of proinﬂammatory cytokines from
skin mast cells. Cells were irradiated with 75 mJ per cm2 UVB, 15 J per
cm2 UVA-1 and 5 J per cm2 PUVA-1, kept in culture for 1 h, and then
triggered or not by anti-IgE. Supernatants were removed after 24 h and
cytokine content assessed by standard ELISA technique. Control
referred to non irradiated and non anti IgE challenged cells, the values
for which were set at 100%. Results are the mean SEM of 4–10
independent tests. po0.05, po0.01, po0.001.
Tables S1. Irradiance data for UV-sources.
Tables S2. Received UV-doses at mast cell site.
Tables S3. Percentage of dead cells.
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